Cross-Border Bets and Delisting Clocks: Micro-Cap Biotech Fractures Under Liquidity SqueezeGlobal Report·Aug 19 at 05:12 AMBIYA-0.86%ADTX-14.06%
TECOGEN INC. 2026: Revenue $5.75M, EPS ($0.07) — 10-Q SummaryTradingView·Aug 13 at 01:01 PMTGEN-1.57%VRT+3.15%
TGEN: Revenue fell 21% but backlog and data center traction signal growth aheadQuartr·Aug 13 at 10:06 AMTGEN-1.57%
Tecogen GAAP EPS of -$0.07 misses by $0.01, revenue of $5.75M misses by $1.55Mbusinessinsider·Aug 12 at 11:56 PMTGEN-1.57%
Tecogen: Buy Rating Reaffirmed as Data Center Pipeline Strengthens and $7.5 Price Target MaintainedTip Ranks·Aug 12 at 05:05 PMTGEN-1.57%
Tecogen | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 5.746 MEarnings Watch·Aug 12 at 04:47 PMTGEN-1.57%
Tecogen Q2 FY26 net loss widens 46.8% to $2.15 million; revenue falls 21.2% to $5.75 millionPUBT·Aug 12 at 03:57 PMTGEN-1.57%
Tecogen Reports Second Quarter 2026 Financial Results | TGEN Stock NewsStockTitan·Aug 12 at 08:00 AMTGEN-1.57%
Fringe Assets and Flawed Excuses: Stop Blaming AIGlobal Report·Aug 12 at 05:13 AMFVRR-1.15%TGEN-1.57%
Tecogen Schedules Earnings Release Date and Conference Call for Q2 2026 Results | TGEN Stock NewsStockTitan·Jul 31 at 07:45 AMTGEN-1.57%
